Summary

Contract Research And Manufacturing Service (CRAMS) Market In India 2024-2028
The contract research and manufacturing service (CRAMS) market in India is forecasted to grow by USD 14.08 bn during 2023-2028, accelerating at a CAGR of 10.8% during the forecast period. The report on the contract research and manufacturing service (CRAMS) market in India provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by diverse range of service offerings by CRAMS providers, availability of cost-effective solutions for research, development, and manufacturing services, and presence of highly skilled workforce in pharmaceutical sciences and biotechnology.
Technavio's contract research and manufacturing service (CRAMS) market in India is segmented as below:
By Service
• Manufacturing
• Research
By Therapeutic Area
• Cardiovascular
• Infectious disease
• Endocrine disease
• Oncology
• Gastrointestinal and others
By End-user
• Pharmaceutical and biopharmaceutical companies
• Medical device companies
• Academic and research institutes
By Geographical Landscape
• APAC
This study identifies the technological advancements in CRAMS as one of the prime reasons driving the contract research and manufacturing service (CRAMS) market in India growth during the next few years. Also, increasing number of US FDA-approved manufacturing facilities and increasing outsourcing of research and manufacturing activities by AMEs will lead to sizable demand in the market.
The report on the contract research and manufacturing service (CRAMS) market in India covers the following areas:
• Contract research and manufacturing service (CRAMS) market in India sizing
• Contract research and manufacturing service (CRAMS) market in India forecast
• Contract research and manufacturing service (CRAMS) market in India industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading contract research and manufacturing service (CRAMS) market in India vendors that include Aragen Life Sciences Pvt. Ltd., Arch Pharmalabs Ltd., Aurobindo Pharma Ltd., BHAGWATI ORGANICS PVT. LTD., Biocon Ltd., Dhanuka Agritech Ltd., Dishman Carbogen Amcis Ltd., Divis Laboratories Ltd., Ind Swift Laboratories Ltd., Ipca Laboratories Ltd., Jubilant Pharmova Ltd., Lupin Ltd., Merck and Co. Inc., MSN Laboratories, Murli Krishna Pharma, Piramal Enterprises Ltd., Solara, Sun Pharmaceutical Industries Ltd., TCG Lifesciences Pvt. Ltd., and Wockhardt Ltd.. Also, the contract research and manufacturing service (CRAMS) market in India analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/india-contract-research-and-manufacturing-service-crams-market-in-2024-2028-industry-analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

Table of Contents

- 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Country Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market Segmentation by Service
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapeutic Area
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
- 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 08: Parent market
o Exhibit 09: Market Characteristics
- 3 Market Sizing
o 3.1 Market definition
o Exhibit 10: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 11: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 12: Chart on India - Market size and forecast 2023-2028 ($ billion)
o Exhibit 13: Data Table on India - Market size and forecast 2023-2028 ($ billion)
o Exhibit 14: Chart on India: Year-over-year growth 2023-2028 (%)
o Exhibit 15: Data Table on India: Year-over-year growth 2023-2028 (%)
- 4 Historic Market Size
o 4.1 Contract research and manufacturing service (CRAMS) market in India 2018 - 2022
o Exhibit 16: Historic Market Size - Data Table on contract research and manufacturing service (crams) market in India 2018 - 2022 ($ billion)
o 4.2 Service Segment Analysis 2018 - 2022
o Exhibit 17: Historic Market Size - Service Segment 2018 - 2022 ($ billion)
o 4.3 Therapeutic area Segment Analysis 2018 - 2022
o Exhibit 18: Historic Market Size - Therapeutic area Segment 2018 - 2022 ($ billion)
o 4.4 End-user Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
- 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 20: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 23: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 24: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 25: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 26: Chart on Market condition - Five forces 2023 and 2028
- 6 Market Segmentation by Service
o 6.1 Market segments
o Exhibit 27: Chart on Service - Market share 2023-2028 (%)
o Exhibit 28: Data Table on Service - Market share 2023-2028 (%)
o 6.2 Comparison by Service
o Exhibit 29: Chart on Comparison by Service
o Exhibit 30: Data Table on Comparison by Service
o 6.3 Manufacturing - Market size and forecast 2023-2028
o Exhibit 31: Chart on Manufacturing - Market size and forecast 2023-2028 ($ billion)
o Exhibit 32: Data Table on Manufacturing - Market size and forecast 2023-2028 ($ billion)
o Exhibit 33: Chart on Manufacturing - Year-over-year growth 2023-2028 (%)
o Exhibit 34: Data Table on Manufacturing - Year-over-year growth 2023-2028 (%)
o 6.4 Research - Market size and forecast 2023-2028
o Exhibit 35: Chart on Research - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Data Table on Research - Market size and forecast 2023-2028 ($ billion)
o Exhibit 37: Chart on Research - Year-over-year growth 2023-2028 (%)
o Exhibit 38: Data Table on Research - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Service
o Exhibit 39: Market opportunity by Service ($ billion)
o Exhibit 40: Data Table on Market opportunity by Service ($ billion)
- 7 Market Segmentation by Therapeutic Area
o 7.1 Market segments
o Exhibit 41: Chart on Therapeutic Area - Market share 2023-2028 (%)
o Exhibit 42: Data Table on Therapeutic Area - Market share 2023-2028 (%)
o 7.2 Comparison by Therapeutic Area
o Exhibit 43: Chart on Comparison by Therapeutic Area
o Exhibit 44: Data Table on Comparison by Therapeutic Area
o 7.3 Cardiovascular - Market size and forecast 2023-2028
o Exhibit 45: Chart on Cardiovascular - Market size and forecast 2023-2028 ($ billion)
o Exhibit 46: Data Table on Cardiovascular - Market size and forecast 2023-2028 ($ billion)
o Exhibit 47: Chart on Cardiovascular - Year-over-year growth 2023-2028 (%)
o Exhibit 48: Data Table on Cardiovascular - Year-over-year growth 2023-2028 (%)
o 7.4 Infectious disease - Market size and forecast 2023-2028
o Exhibit 49: Chart on Infectious disease - Market size and forecast 2023-2028 ($ billion)
o Exhibit 50: Data Table on Infectious disease - Market size and forecast 2023-2028 ($ billion)
o Exhibit 51: Chart on Infectious disease - Year-over-year growth 2023-2028 (%)
o Exhibit 52: Data Table on Infectious disease - Year-over-year growth 2023-2028 (%)
o 7.5 Endocrine disease - Market size and forecast 2023-2028
o Exhibit 53: Chart on Endocrine disease - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Data Table on Endocrine disease - Market size and forecast 2023-2028 ($ billion)
o Exhibit 55: Chart on Endocrine disease - Year-over-year growth 2023-2028 (%)
o Exhibit 56: Data Table on Endocrine disease - Year-over-year growth 2023-2028 (%)
o 7.6 Oncology - Market size and forecast 2023-2028
o Exhibit 57: Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
o Exhibit 59: Chart on Oncology - Year-over-year growth 2023-2028 (%)
o Exhibit 60: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
o 7.7 Gastrointestinal and others - Market size and forecast 2023-2028
o Exhibit 61: Chart on Gastrointestinal and others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Data Table on Gastrointestinal and others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 63: Chart on Gastrointestinal and others - Year-over-year growth 2023-2028 (%)
o Exhibit 64: Data Table on Gastrointestinal and others - Year-over-year growth 2023-2028 (%)
o 7.8 Market opportunity by Therapeutic Area
o Exhibit 65: Market opportunity by Therapeutic Area ($ billion)
o Exhibit 66: Data Table on Market opportunity by Therapeutic Area ($ billion)
- 8 Market Segmentation by End-user
o 8.1 Market segments
o Exhibit 67: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 68: Data Table on End-user - Market share 2023-2028 (%)
o 8.2 Comparison by End-user
o Exhibit 69: Chart on Comparison by End-user
o Exhibit 70: Data Table on Comparison by End-user
o 8.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028
o Exhibit 71: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
o 8.4 Medical device companies - Market size and forecast 2023-2028
o Exhibit 75: Chart on Medical device companies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Medical device companies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Medical device companies - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Medical device companies - Year-over-year growth 2023-2028 (%)
o 8.5 Academic and research institutes - Market size and forecast 2023-2028
o Exhibit 79: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
o 8.6 Market opportunity by End-user
o Exhibit 83: Market opportunity by End-user ($ billion)
o Exhibit 84: Data Table on Market opportunity by End-user ($ billion)
- 9 Customer Landscape
o 9.1 Customer landscape overview
o Exhibit 85: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 86: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
- 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 87: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 88: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 89: Impact of key risks on business
- 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 90: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 91: Matrix on vendor position and classification
o 12.3 Aragen Life Sciences Pvt. Ltd.
o Exhibit 92: Aragen Life Sciences Pvt. Ltd. - Overview
o Exhibit 93: Aragen Life Sciences Pvt. Ltd. - Product / Service
o Exhibit 94: Aragen Life Sciences Pvt. Ltd. - Key offerings
o 12.4 Aurobindo Pharma Ltd.
o Exhibit 95: Aurobindo Pharma Ltd. - Overview
o Exhibit 96: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 97: Aurobindo Pharma Ltd. - Key offerings
o 12.5 Biocon Ltd.
o Exhibit 98: Biocon Ltd. - Overview
o Exhibit 99: Biocon Ltd. - Business segments
o Exhibit 100: Biocon Ltd. - Key news
o Exhibit 101: Biocon Ltd. - Key offerings
o Exhibit 102: Biocon Ltd. - Segment focus
o 12.6 Dhanuka Agritech Ltd.
o Exhibit 103: Dhanuka Agritech Ltd. - Overview
o Exhibit 104: Dhanuka Agritech Ltd. - Business segments
o Exhibit 105: Dhanuka Agritech Ltd. - Key offerings
o Exhibit 106: Dhanuka Agritech Ltd. - Segment focus
o 12.7 Dishman Carbogen Amcis Ltd.
o Exhibit 107: Dishman Carbogen Amcis Ltd. - Overview
o Exhibit 108: Dishman Carbogen Amcis Ltd. - Business segments
o Exhibit 109: Dishman Carbogen Amcis Ltd. - Key offerings
o Exhibit 110: Dishman Carbogen Amcis Ltd. - Segment focus
o 12.8 Divis Laboratories Ltd.
o Exhibit 111: Divis Laboratories Ltd. - Overview
o Exhibit 112: Divis Laboratories Ltd. - Product / Service
o Exhibit 113: Divis Laboratories Ltd. - Key offerings
o 12.9 Ipca Laboratories Ltd.
o Exhibit 114: Ipca Laboratories Ltd. - Overview
o Exhibit 115: Ipca Laboratories Ltd. - Product / Service
o Exhibit 116: Ipca Laboratories Ltd. - Key offerings
o 12.10 Jubilant Pharmova Ltd.
o Exhibit 117: Jubilant Pharmova Ltd. - Overview
o Exhibit 118: Jubilant Pharmova Ltd. - Business segments
o Exhibit 119: Jubilant Pharmova Ltd. - Key offerings
o Exhibit 120: Jubilant Pharmova Ltd. - Segment focus
o 12.11 Lupin Ltd.
o Exhibit 121: Lupin Ltd. - Overview
o Exhibit 122: Lupin Ltd. - Product / Service
o Exhibit 123: Lupin Ltd. - Key news
o Exhibit 124: Lupin Ltd. - Key offerings
o 12.12 Merck and Co. Inc.
o Exhibit 125: Merck and Co. Inc. - Overview
o Exhibit 126: Merck and Co. Inc. - Business segments
o Exhibit 127: Merck and Co. Inc. - Key news
o Exhibit 128: Merck and Co. Inc. - Key offerings
o Exhibit 129: Merck and Co. Inc. - Segment focus
o 12.13 MSN Laboratories
o Exhibit 130: MSN Laboratories - Overview
o Exhibit 131: MSN Laboratories - Product / Service
o Exhibit 132: MSN Laboratories - Key offerings
o 12.14 Piramal Enterprises Ltd.
o Exhibit 133: Piramal Enterprises Ltd. - Overview
o Exhibit 134: Piramal Enterprises Ltd. - Product / Service
o Exhibit 135: Piramal Enterprises Ltd. - Key offerings
o 12.15 Sun Pharmaceutical Industries Ltd.
o Exhibit 136: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 137: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 138: Sun Pharmaceutical Industries Ltd. - Key news
o Exhibit 139: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.16 TCG Lifesciences Pvt. Ltd.
o Exhibit 140: TCG Lifesciences Pvt. Ltd. - Overview
o Exhibit 141: TCG Lifesciences Pvt. Ltd. - Product / Service
o Exhibit 142: TCG Lifesciences Pvt. Ltd. - Key offerings
o 12.17 Wockhardt Ltd.
o Exhibit 143: Wockhardt Ltd. - Overview
o Exhibit 144: Wockhardt Ltd. - Product / Service
o Exhibit 145: Wockhardt Ltd. - Key offerings
- 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 146: Inclusions checklist
o Exhibit 147: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 148: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 149: Research methodology
o Exhibit 150: Validation techniques employed for market sizing
o Exhibit 151: Information sources
o 13.5 List of abbreviations
o Exhibit 152: List of abbreviations